Abstract
Utility of circulating tumor DNA (ctDNA) as a predictive biomarker for disease monitoring in patients with non-seminomatous germ-cell tumor (NSGCT).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have